Category Archives: Cancer
Top 15 private biotech companies of 2015
Alector: “We are developing drug leads against unique, genetically-validated neuro-immune targets through a novel, hypothesis-driven approach to neurodegeneration. We thankFierceBiotech for recognizing the potential of our strategy,” said Arnon Rosenthal, co-founder, president and CEO of Alector. Release
Arvinas: “We are thrilled to be selected by FierceBiotech to be among the top private biotech firms globally,” Manuel Litchman, president and chief executive officer of Arvinas, said. “This award recognizes the dedication of our employees, our founder, Dr. Craig Crews, and our partners to bring our PROTAC technologies to patients with … Read more
Adoptive Cell Therapy – Update
Gene Therapy and regenerative medicine companies.
ABEONA THERAPEUTICS
Tim Miller, Ph.D., President & CEO
Dallas, TX
(NASDAQ: ABEO)
PlasmaTech Biopharmaceuticals/Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. PlasmaTech’s lead program is a gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. In addition, the company is pursuing two additional proprietary platforms, Salt Diafiltration (SDF™) Process and Polymer Hydrogel Technology (PHT™), and is active in the development and commercialization of human plasma-derived therapeutics, including its proprietary
NantKwest – Immunotherapy company using the natural killer cell to treat cancer.
NantKwest – Immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Natural killer, or NK, cells are the body’s first line of defense due to their innate ability to rapidly seek and destroy abnormal cells, such as cancer or virally-infected cells, without prior exposure or activation by other support molecules required to activate adaptive immune cells such as T-cells.… Read more
Immuno-Oncology Big Deals
The immune system is the body’s natural defence system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. When a different (foreign) organism enters into the body, for example a bacteria, the immune system recognises it and then attacks it, preventing it from causing harm. This process is called an immune response. Since cancer cells are very different from normal cells in the body, the immune system attacks them when it is able to recognise them. However, cancer cells … Read more
A Fundamental Transformation in Treating Cancer—Combining Modern Technology and the Immune System – UC Global Health Day 2015
A Fundamental Transformation in Treating Cancer—Combining Modern Technology and the Immune System – UC Global Health Day 2015… Read more
Acitinium Pharmaceuticals
Acute Myeloid Leukemia is the deadliest form of leukemia that affects mostly people over 60 years of age. ATNM’s most advanced product candidate is indicated for relapsed/refractory AML in adults 55 years and older. Of those, 64% do not receive any treatment other than supportive. The Company believes that upon continued demonstration of the current safety profile of the drug candidate its target indication can be expanded to include all elderly patients with newly diagnosed AML.… Read more
Last 20 Oncologic Drugs Approved
From January 1, 2009, to December 31, 2013, the US FDA approved 51 drugs in oncology for 63 indications. During this time, 9 drugs received more than 1 approved indication. The Table lists the last 20 drugs (total of 21 approvals) approved by the FDA and their median wholesale prices.
More… Read more